期刊文献+

舒脑欣滴丸治疗急性缺血性中风73例临床观察 被引量:17

A Clinical Observation on Shunaoxin Dropping Pills for 73 Cases of Acute Ischemic Stroke
原文传递
导出
摘要 目的观察舒脑欣滴丸治疗急性缺血性中风血瘀证的临床疗效,并探讨其作用机制。方法选择急性缺血性中风血瘀证患者154例,随机分为对照组81例(常规治疗)和试验组73例(常规治疗+舒脑欣滴丸),两组均治疗2周。于治疗前后评价中医症状积分、卒中量表(NIHSS)评分,并检测两组患者血小板计数(PLT)、平均血小板体积(MPV)、血小板聚集率、凝血酶原时间(PT)、凝血活酶时间(APTT)、血浆凝血酶时间(TT)、纤维蛋白原(FIB)、可溶性P-选择素(sP-sel)、可溶性CD40L(sCD40L)水平。结果两组患者治疗后中医症状积分、NIHSS评分、MPV均显著减低(P<0.05或P<0.01);试验组治疗后血小板聚集率、sP-sel、sCD40L显著减低,APTT增加(P<0.05或P<0.01);治疗后试验组NIHSS评分、血小板聚集率显著低于对照组,APTT显著高于对照组(P<0.05或P<0.01)。结论舒脑欣滴丸可改善急性缺血性中风血瘀证患者的中医临床症状及神经功能缺损症状,其作用机制可能与抑制血小板活化、聚集,干预内源性凝血途径有关。 Objective To observe the therapeutic effect and mechanism of Shunaoxin Dropping Pill for acute ischemic stroke (AIS) with blood stasis pattern. Methods Totally 154 AIS patients with blood stasis pattern were randomized into the control group (81 cases, conventional therapy) and trail group (73 cases, conventional therapy+Shunaoxin Dropping Pill). The treat- ment lasted for 14 days. The scores of TCM symptom scale and National Institutes of Health Stroke Scale (NIHSS) were evaluated on the admission day and after treatment. The platelet count (PLT), mean platelet volume (MPV), platelet aggrega- tion rate, prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen (FIB), soluble P-selectin (sP-sel) and soluble CD40L (sCD40L) were detected. Results The TCM symptom scale score, NIHSS score and MPV were significantly decreased in both groups after treatment (P〈0.05 or P〈0.01). The platelet aggregation rate, sP-sel and sCD40L were significantly decreased but the APTT were significantly increased in the trail group after treat- ment (P〈C0.05 or P〈0.01). After treatment, the NIHSS score and platelet aggregation rate in the trail group were signifi- cantly lower than those in the control group, but the APTT in the trail group was significantly higher than that in the control group (P〈0.05 or P〈0.01). Conclusion Shunaoxin Dropping Pill can relieve the TCM symptoms and neurological deficit that may be relevant to inhibiting the platelet activation and aggregation and intervening the intrinsic coagulation pathway.
出处 《中医杂志》 CSCD 北大核心 2013年第9期758-761,共4页 Journal of Traditional Chinese Medicine
基金 天津市中医药管理局中医 中西医结合科研课题(11037)
关键词 舒脑欣滴丸 缺血性中风 血瘀证 卒中量表 神经功能 Shunaoxin Dropping Pill ischemic stroke blood stasis pattern NIHSS nerve function
  • 相关文献

参考文献11

  • 1武晓娟,史卫峰,黄燕,魏强,俞惠琴,郑建全.芎归滴丸对小鼠急性脑梗死的预防作用及其机制分析[J].解放军药学学报,2007,23(6):420-422. 被引量:5
  • 2凌婧,邓文龙,张杰,李兴平,杨芳炬.川芎油对大鼠脑缺血再灌注后脑组织ICAM-1、血浆TNF-α及ET的影响[J].中药药理与临床,2008,24(4):32-34. 被引量:11
  • 3康建策,钱海燕,蔡文.舒脑欣滴丸治疗椎-基底动脉供血不足的临床观察[J].北京中医药大学学报(中医临床版),2008,15(3):15-16. 被引量:9
  • 4中国急性缺血性脑卒中诊治指南2010[J].中华神经科杂志,2010,43(2):146-153. 被引量:3401
  • 5Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale [J]. Arch Neurol,1989, 46(6) : 660 - 662.
  • 6国家中医药管理局脑病急症科研组.中风病辨证诊断标准(试行).北京中医药大学学报,1994,17(3):64-66.
  • 7Pikiia S, Cvetko D, Hajduk M, et al. Higher mean platelet volume determined shortly after the symptom on- set in acute ischemic stroke patients is associated with a larger infarct volume on CT brain scans and with worse clinical outcome[J]. Clin Neurol Neurosurg, 2009, 111 (7) :568 - 573.
  • 8Greisenegger S, Endler G, Hsieh K, et al. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? [J]. Stroke, 2004, 35(7) :1688 - 1691.
  • 9Andre P, Hartwell D, Hraehovinova I, et al. Pro-coag- ulant state resulting from high levels of soluble P-selec- tin in blood[J]. Proc Natl Acad Sci USA, 2000, 97 (25) :13835 - 13840.
  • 10Nagy Jr B, Miszti-Blasius K, Kerenyi A, et al. Poten- tial Therapeutic Targeting of Platelet-Mediated Cellular Interactions in Atherosclerosis and Inflammation [J]. Curt Med Chem, 2012, 19(4) :518 - 531.

二级参考文献44

共引文献3705

同被引文献253

引证文献17

二级引证文献177

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部